Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jie Ma
Institution:
First Affiliated Hospital of GuangXi Medical University
Observed institutions:
Guangxi Medical University,
First Affiliated Hospital of GuangXi Medical University
ORCID:
0009-0003-4536-0931
Observed ORCID:
0009-0003-4536-0931
OpenAlex ID:
A5015830417
Anlotinib Combined With Toripalimab as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Prospective, Multicenter, Phase II Study
2023
·
Cheng-Sheng Zhang
, Zhi-Ming Zeng
, et al.
·
The Oncologist
·
21
PDF
Unusual presentation of primary ovarian diffuse large B-cell lymphoma: a case report
2022
·
Bin Luo
, Rong-quan He
, et al.
·
Journal of Ovarian Research
·
14
PDF
Stereotactic body radiation therapy combined with cadonilimab and lenvatinib in the treatment of hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombus: a prospective, multicenter, single-arm, phase II clinical trial
2025
·
Ning Mo
, Kai Hu
, et al.
·
Frontiers in Immunology
·
7
PDF
Anlotinib plus toripalimab as first-line treatment for patients with unresectable hepatocellular carcinoma: Updated results of the ALTER-H003 trial.
2023
·
Haifeng Lin
, Jie Ma
, et al.
·
Journal of Clinical Oncology
·
4
Tislelizumab in combination with anlotinib as first-line treatment for unresectable hepatocellular carcinoma: A single-arm, phase II clinical trial.
2023
·
Shi-xue Laoguo
, Huasheng Huang
, et al.
·
Journal of Clinical Oncology
·
3
Neoadjuvant transhepatic arterial infusion chemotherapy (HAIC) with FOLFOX regime plus cadonilimab (PD-1/CTLA-4 bispecific antibody) for resectable multinodular CNLC Ib/IIa hepatocellular carcinoma (CAR_Hero study).
2025
·
Yongguang Wei
, GuangZhi Zhu
, et al.
·
Journal of Clinical Oncology
·
2
Envafolimab (KN035) plus gemcitabine and oxaliplatin (GEMOX) compared with GEMOX as first-line treatment for Chinese patients with advanced biliary tract cancer: A randomized, open-label, multi-center, phase III pivotal trial.
2026
·
Shukui Qin
, Weijia Fang
, et al.
·
Journal of Clinical Oncology
·
1
SHR-8068 plus adebrelimab and bevacizumab for advanced hepatocellular carcinoma (aHCC): A phase 1b/2 study.
2025
·
Lianxin Liu
, Jiabei Wang
, et al.
·
Journal of Clinical Oncology
·
1
Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing
2023
·
Lili Deng
, Jingjing Zeng
, et al.
·
Medicine
·
1
Overexpression of UBE2C in Esophageal Squamous Cell Carcinoma Tissues and Molecular Analysis
2021
·
Rong Li
, xingfeng pang
, et al.
·
Research Square
·
1
PDF
Machine Learning Applications in Heart Failure: A Protocol for a Scoping Review of Systematic Reviews and Meta-Analyses
2025
·
Hai Bin Wu
, Kun Wu
, et al.
PDF
Anlotinib hydrochloride combined with tislelizumab, paclitaxel liposome, and nedaplatin regimen for preoperative neoadjuvant therapy of esophageal cancer: A single-arm, single-center, phase II exploratory clinical study.
2023
·
Jie Ma
, Cuizhen Liu
, et al.
·
Journal of Clinical Oncology
PDF
Establishment and Validation of a Risk Prediction Model for Venous Thromboembolism in Lung Cancer Based on a Meta-Analysis
2023
·
Angui Liu
, Rongquan He
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
13
Citation count:
55
H-index:
4
I10-index:
2
Year
Topic
Type